MedPath
NMPA Approval

Albipagrastim alfa for Injection

国药准字S20250021

May 27, 2025

Drug Information

注射用阿格司亭α

迈粒生

注射剂

20mg/瓶

生物制品

May 27, 2025

Company Information

Applicant Company

泰州市药城大道1号G03幢厂房

Manufacturing Company

泰州市健康大道803号G55幢

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用阿格司亭α - NMPA 批准文号 | MedPath